Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - OPERATING INCOME
Operating Income DNLI - Denali Therapeutics Inc.
-197 M
LAST VALUE
18.45%
2 YEAR CAGR
-33.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR